Schedule 13G ownership disclosure

ABVC BIOPHARMA INC

Common Stock, par value $0.001 per share · CUSIP: 00091F304

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Lind Global Fund II LP

    Shares: 1,325,000 · Class: 9.9%

  • Lind Global Partners II LLC

    Shares: 1,325,000 · Class: 9.9%

  • EASTON JEFF

    Shares: 1,325,000 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000929638-25-000810
Form type
SCHEDULE 13G/A
Filer
ABVC BIOPHARMA, INC.
CIK
CIK 1173313
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub